# Alaron Products Limited - Inspection Records

Source: https://www.keypedia.com/companies/alaron-products-limited/637fe75b-c4b2-4793-927d-b44f270c21f8

> Inspection records and compliance data for Alaron Products Limited in Nelson, None. Access full analysis and detailed observations.

---

## Details

- Name: Alaron Products Limited
- FEI Number: 3009057446
- City: Nelson
- State: None
- Country Name: New Zealand
- Address Line 1: 13 Bolt Road Tahunanui
- Zip Code: None

## Related Documents

- [FDA Inspection 1195390 - Alaron Products Limited - 2023-01-12](https://www.keypedia.com/records/fda_inspections/alaron-products-limited/630fe4e0-a0de-4aa7-a17e-35f4b492bec3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 12, 2023

## Related Companies

- [Alexza Pharmaceuticals, Inc.](https://www.keypedia.com/companies/alexza-pharmaceuticals-inc/4b71680e-1a0e-4237-8b2a-2e2c32c5c8fe)
- [Apotex, Inc.](https://www.keypedia.com/companies/apotex-inc/3fb3d66a-fef9-4c47-82b5-da446ecf3593)
- [Catalent Germany Eberbach GmbH](https://www.keypedia.com/companies/catalent-germany-eberbach-gmbh/fcf97f2a-c54b-4105-afc0-11a0c999d8a5)
- [SWISSCAPS Romania SRL](https://www.keypedia.com/companies/swisscaps-romania-srl/16482726-eaba-4a39-bbc5-b0861409684f)
- [Forest Laboratories Ireland Limited](https://www.keypedia.com/companies/forest-laboratories-ireland-limited/6d308a71-830b-4cbc-9314-2a44f9290d1f)
- [Otsuka Pharmaceutical Co. Ltd.](https://www.keypedia.com/companies/otsuka-pharmaceutical-co-ltd/5a397250-e719-4d0b-9a66-64f88d34da89)
- [Excite Pharma Services LLC](https://www.keypedia.com/companies/excite-pharma-services-llc/05ab029c-7828-4cd1-87f5-0b05fb0b7db1)
- [Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/otsuka-pharmaceutical-co-ltd/3f09b45f-4a0a-465d-b90f-73a74ca3e59b)
- [3M Company](https://www.keypedia.com/companies/3m-company/09a7a39c-a8e7-459a-9f6f-22733c1bdce3)
- [Alexion Pharma LLC](https://www.keypedia.com/companies/alexion-pharma-llc/52870438-fc99-4463-b429-73b6b9c9515c)